Factors Affecting the Prognosis of Early Ovarian Cancer
Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04414683
Collaborator
(none)
300
1
56.6
5.3
Study Details
Study Description
Brief Summary
To elucidate factors affecting survival of early stage ovarian cancer
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
To analyze factors affecting survival of early ovarian cancer, such as cell type, cell grade, intraoperative rupture, and laparoscopy vs. laparotomy, etc.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
300 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Factors Affecting the Prognosis of Early Ovarian Cancer
Actual Study Start Date
:
Apr 13, 2020
Anticipated Primary Completion Date
:
Dec 31, 2024
Anticipated Study Completion Date
:
Dec 31, 2024
Outcome Measures
Primary Outcome Measures
- Factors affecting overall survival of early ovarian cancer [10 years]
Secondary Outcome Measures
- Factors affecting progression-free survival of early ovarian cancer [10 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- early stage ovarian cancer
Exclusion Criteria:
- Nil.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital | Banqiao | New Taipei | Taiwan | 22050 |
Sponsors and Collaborators
- Far Eastern Memorial Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Sheng-Mou Hsiao,
Chief of Department of Obstetrics & Gynecology,
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04414683
Other Study ID Numbers:
- 109058-E
First Posted:
Jun 4, 2020
Last Update Posted:
Feb 8, 2022
Last Verified:
Jun 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: